Is soluble urokinase plasminogen activator receptor ( suPAR ) a novel , independent predictive marker of myocardial infarction in HIV-1-infected patients : a nested case-control study?
Elevated suPAR levels were associated with increased risk of MI in HIV-infected patients, suggesting that suPAR could be a useful biomarker for prediction of first-time MI in this patient group, even years before the event.
Illness perceptions may be important while investigating quality of life in patients with prostate cancer. It may underlie quality-of-life differences in this group of patients and could inform decision makers about the importance of the provision of psychosocial services to patients with prostate cancer.